It appears the manufacturer of Fosamax, the osteoporosis drug, knew about potential serious problems with the drug back in 2004. Fosamax belongs to a family of drugs called bisphosphonates which are believed to cause a severe osteonecrosis. Merck has made $3million from Fosamax and didn’t want to change its labeling for fear of declining sales. Sound familiar?
Merck and Fosamax
It appears the manufacturer of Fosamax, the osteoporosis drug, knew about potential serious problems with the drug back in 2004. Fosamax belongs to a family of drugs called bisphosphonates which are believed to cause a severe osteonecrosis. Merck has made $3million from Fosamax and didn’t want to ch
Tags:
Health
More in Health
See all
